Table 2.
Unadjusted | Adjusted | Adjusted (including amiodarone) | ||||||
---|---|---|---|---|---|---|---|---|
# of events | Risk time | HR [CI] | p | HR [CI] | p | HR [CI] | p | |
CHF | ||||||||
Yes | 124 | 3.75 | 1.22 [1.02–1.43] | 0.001 | 1.86 [1.17–2.94] | 0.006 | 1.23 [1.08–1.39] | 0.002 |
No | 12899 | 4.77 | 0.82 [0.72–0.92] | 0.95 [0.92–0.99] | 0.87 [0.65–1.02] | |||
CAD | ||||||||
Yes | 144 | 4.31 | 1.41 [1.28–1.68] | 0.53 | 1.08 [0.61–1.89] | 0.81 | 1.07 [0.74–1.38] | 0.62 |
No | 12879 | 4.76 | 0.73 [0.64–0.84] | 0.96 [0.92–0.99] | 0.93 [0.86–1.16] | |||
CVD | ||||||||
Yes | 202 | 4.14 | 1.15 [1.01–1.31] | 0.24 | 0.84 [0.59–1.18] | 0.56 | 0.91 [0.72–1.26] | 0.39 |
No | 12821 | 4.77 | 0.9 [0.82–0.99] | 0.96 [0.92–1.00] | 1.11 [1.0–1.22] | |||
Cardiovascular medication use | ||||||||
Yes | 184 | 3.73 | 1.16 [0.98–1.41] | 0.39 | 1.05 [0.81–1.34] | 0.43 | 1.13 [1.03–1.24] | 0.11 |
No | 7993 | 4.78 | 0.89 [0.81–0.97] | 0.96 [0.92–0.99] | 0.89 [0.69–1.09] |
Analyses adjusted for age, sex, race, ethnicity, body mass index, diabetes, hypertension, hyperlipidemia, CHF, CAD, and CVD.